Anavex Life Sciences (AVXL) Stock: Buy, Sell, or Hold?
AVXL - Anavex Life Sciences
$2.62
-0.04 (-1.50%)
▼
5d:
-8.07%
30d:
-23.17%
90d:
+4.8%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 25, 2026
0d
Get Alerted When AVXL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: AVXL shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: AVXL shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: AVXL is currently trading at $2.62, which is considered oversold relative to its 30-day fair value range of $2.91 to $3.36. From a valuation perspective, the stock is trading at a discount (Forward PE: -4.8) compared to its historical average (4.3). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, AVXL is showing sideways momentum. The price is currently testing key support at $2.61. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $20.00 (+663.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AVXL is showing sideways momentum. The price is currently testing key support at $2.61. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $20.00 (+663.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.91 -
$3.36
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
Protect Your Profits
Holding AVXL? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 663.4% below Wall St target ($20.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 51/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.91 -
$3.36
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.61
Resistance Level
$3.13
Current Trend
Sideways
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.76
Wall Street Target
$20.00
(+663.4%)
PE vs Historical
-4.8 vs 4.3
CHEAP
Share & Embed Analysis
Last updated: September 13, 2026 8:05 AM ET
Data refreshes hourly during market hours. Next update: 9:05 AM
Data refreshes hourly during market hours. Next update: 9:05 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AVXL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 52 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 49 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 50 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 41 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 48 HOLD |
Advanced AVXL Option Strategies
Professional options setups generated by AI based on today's AVXL price and gamma walls.
